鍏借嵂鍚嶇О |
鐢熶骇鍘傚悕绉� |
鍥� 鍒� |
杩涘彛鍏借嵂娉ㄥ唽璇佷功鍙� |
鏈夋晥 鏈熼檺 |
澶囨敞 |
澶嶆柟鐢查啗婧舵恫 Compound Formaldehyde Solution |
涓栧痉鏉ユ湁闄愬叕鍙� CID Lines NV/SA |
姣斿埄鏃� |
锛�2017锛夊鍏借嵂璇佸瓧85鍙� |
2017.11.21 - 2022.11.20 |
鍐嶆敞鍐� |
姘㈠寲鍙殑鏉鹃唻涓欓叝鍠峰墏 Hydrocortisone Aceponate Spray |
娉曞浗缁村厠鏈夐檺鍏徃 Virbac S.A. |
娉曞浗 |
锛�2017锛夊鍏借嵂璇佸瓧86鍙� |
2017.11.21 - 2022.11.20 |
鍐嶆敞鍐� |
浠旂尓C鍨嬩骇姘旇崥鑶滄鑿岀梾銆佸ぇ鑲犳潌鑿岀梾浜岃仈鐏椿鐤嫍 Clostridium Perfringens Type C - Escherichia Coli Bacterin-Toxoid |
纭曡吘鍏徃缇庡浗鏋楄偗鐢熶骇鍘� Zoetis Inc.,Lincoln,USA |
缇庡浗 |
锛�2017锛夊鍏借嵂璇佸瓧87鍙� |
2017.11.21 - 2022.11.20 |
鍐嶆敞鍐� |
澶氭潃闇夌礌鍜€鍤肩墖 Spinosad Chewable Tablets |
缇庡浗鑹句集缁村叕鍙� AbbVie Inc. |
缇庡浗 |
锛�2015锛夊鍏借嵂璇佸瓧25鍙� |
2015.05 - 2020.04 |
鍙樻洿娉ㄥ唽锛氬鍔犻澏鍔ㄧ墿鐚� |
鐚敮鍘熶綋鑲虹値澶嶅悎浣愬墏鐏椿鐤嫍锛圥鏍級 Swine Mycoplasma Hyopneumoniae Vaccine in Compound Adjuvant锛孖nactivated锛圫train P锛� |
缇庡浗娉曠帥濞佺敓鐗╁埗鍝佽偂浠芥湁闄愬叕鍙� Pharmgate Biologics Inc. |
缇庡浗 |
锛�2017锛夊鍏借嵂璇佸瓧17鍙� |
2017.03.14 - 2022.03.13 |
鍙樻洿娉ㄥ唽锛氫紒涓氬悕绉板拰鐢熶骇鍘備腑鑻辨枃鐢�“缇庡浗鏅嘲鍏嬪浗闄呮湁闄愬叕鍙窹rotaTek International, Inc.”鍙樻洿涓�“缇庡浗娉曠帥濞佺敓鐗╁埗鍝佽偂浠芥湁闄愬叕鍙窹harmgate Biologics Inc.” |
鐚敮鍘熶綋鑲虹値鐏椿鐤嫍锛圥鏍級 Swine Mycoplasma Hyopneumoniae Vaccine锛孖nactivated锛圫train P锛� |
缇庡浗娉曠帥濞佺敓鐗╁埗鍝佽偂浠芥湁闄愬叕鍙� Pharmgate Biologics Inc. |
缇庡浗 |
锛�2016锛夊鍏借嵂璇佸瓧56鍙� |
2016.11.29 - 2021.11.28 |
銆€銆€鏍规嵁銆�鍏借嵂绠$悊鏉′緥銆嬪拰銆婂吔鑽敞鍐屽姙娉曘€嬭瀹氾紝缁忓鏌ワ紝鎵瑰噯涓栧痉鏉ユ湁闄愬叕鍙哥瓑3瀹跺叕鍙哥敓浜х殑澶嶆柟鐢查啗婧舵恫绛�3绉嶅吔鑽骇鍝佸湪鎴戝浗鍐嶆敞鍐岋紝鏍稿彂銆婅繘鍙e吔鑽敞鍐岃瘉涔︺€嬶紝骞跺彂甯冧慨璁㈠悗鐨勪骇鍝佽川閲忔爣鍑嗐€佽鏄庝功鍜屾爣绛撅紝鑷彂甯冧箣鏃ヨ捣鎵ц锛屽師鎴戦儴鍙戝竷鐨勬湰浜у搧璐ㄩ噺鏍囧噯銆佽鏄庝功鍜屾爣绛惧悓鏃跺簾姝€€�
銆€銆€鐗规鍏憡銆�
銆€銆€闄勪欢锛�1.杩涘彛鍏借嵂娉ㄥ唽鐩綍
銆€銆€2.璐ㄩ噺鏍囧噯
銆€銆€3.璇存槑涔﹀拰鏍囩
銆€銆€鍐滀笟閮�
銆€銆€2017骞�11鏈�21鏃�
銆€銆€闄勪欢1
銆€銆€杩涘彛鍏借嵂娉ㄥ唽鐩綍